Funding you earn now, next payment 00:00 UTC+0.0033%/8h= +3.6% APRpaid last 24h +0.010%
Price spread now: Injective against HTX−0.909%7-day average — · you buy dearer than you sell
to open and closeno order booka leg has no order-book sample
Funding, last 4 days (all we have)—no history yet
+Price spread, last 7 days—no price history on both exchanges yet
=Together, before fees—needs both histories
Funding pays, the price is against you. Injective is 0.909% cheaper against HTX than usual: you would sell low and buy high (spread −0.909% now, against zero (this spread has no 7-day history yet)). If the spread goes back, that is −$91 on $10k: about 3 months of funding at the current rate (+$1 a day).
| Leg | Exchange | Price | Funding /8h | Each payment | Next in | OI | Vol 24h | Max lev |
|---|---|---|---|---|---|---|---|---|
| Long | HTX NKE-USDT | 36.290 | 0 | get 0.0000% / 8h | 42m 40s | $5K | $307K | 20x |
| Short | Injective NKE/USDC PERP | 35.960 | 0.0033 | get 0.0004% / 1h | 42m 40s | $975 | $11K | 12x |
HTX NKE-USDT
Injective NKE/USDC PERPFunding history
latest
Range statsloading…
Price spread between the two exchanges
Injective against HTX. Falling: the short leg gains. Rising: it loses.latest
Price spreadloading…
Funding on every exchange
click an exchange to add or hide itlatest
How often the price spread is this wide · share of time at each level, last 7D show
Profit calculator
- Funding earned
- $7
- Price spread: −0.909% → 0.000%
- −$90.93
- Slippage, 4 orders
- no order book: not counted
- Fee HTX: 6 bp × 2 orders
- −$12
- Fee Injective: 0.01 bp × 2 orders
- −$0.02
- Net
- −$95.95
- Costs to cover
- 0.120%
- Break-even
- 103.0 days
Slippage unknown: HTX: live order book, 34 min ago; Injective: no order-book sample. Net counts fees only.
Cost to enter
taker fee + slippage from the mid, one side; closing costs about the same again| Leg | Half-spread | $10k | $100k | $1M | $5M |
|---|---|---|---|---|---|
| Buy HTX live order book, 34 min ago | 60.72 bp | doesn't fit | doesn't fit | doesn't fit | doesn't fit |
| Sell Injective no order-book sample | — | — | — | — | — |
Injective: no order-book sample. Either the market is below $100k of open interest and volume (not sampled), or the venue executes at an oracle price and its slippage is not modeled here: see the venue's docs.
NKE on 5 venues
lowest funding first. Swap a leg: a good short leg pays more funding and is priced higher.| Exchange | Funding /8h | Every | Price | Price vs long leg | OI | Vol 24h | Max lev | |
|---|---|---|---|---|---|---|---|---|
| QFEX NKE-USD | 0.0000% | 1h | 36.180 | −0.303% | $1.1M | $979K | 10x | as long as short |
| Gate NKE_USDT | 0.0000% | 8h | 36.190 | −0.276% | $238K | $19K | 20x | as long as short |
| HTX NKE-USDTlong | 0.0000% | 8h | 36.290 | long leg | $5K | $307K | 20x | |
| Injective NKE/USDC PERPshort | +0.0033% | 1h | 35.960 | −0.909% | $975 | $11K | 12x | |
| Bitget NKEUSDT | +0.0645% | 8h | 36.218 | −0.198% | $3.1M | $1.6M | 20x | as long as short |
QFEX NKE-USD
Gate NKE_USDT
Bitget NKEUSDT